Risk factors for death rattle in terminally ill cancer patients: a prospective exploratory study
- 1 January 2000
- journal article
- research article
- Published by SAGE Publications in Palliative Medicine
- Vol. 14 (1) , 19-23
- https://doi.org/10.1191/026921600670897377
Abstract
Death rattle is frequently observed in cancer patients whose death is impending and may contribute to the severe distress of patients and their family members. To identify risk factors for development and persistency of death rattle, a prospective study was performed on 245 hospice inpatients. One-hundred-and-seven patients (44%) developed death rattle, 71% of whom achieved satisfactory symptom palliation until death. A multiple regression analysis identified neoplasms of brain and lung as independent risk factors for development of death rattle, while refractory symptoms were significantly associated with pulmonary neoplasms and infection/oedema. In conclusion, development of death rattle was influenced by both brain and lung malignancies, while its persistency was mainly determined by pulmonary pathology. A clinical classification of death rattle based on these factors would be established by a further confirmatory study.Keywords
This publication has 8 references indexed in Scilit:
- CorrespondenceJournal of Pain and Symptom Management, 1998
- Management of “death rattle”Journal of Pain and Symptom Management, 1996
- Death rattle: An audit of hyoscine (scopolamine) use and review of managementJournal of Pain and Symptom Management, 1996
- Palliative Performance Scale (PPS): A New ToolJournal of Palliative Care, 1996
- Dehydration and the dying patientJournal of Pain and Symptom Management, 1995
- Continuous infusion of haloperidol controls agitation in critically ill patientsCritical Care Medicine, 1994
- The Last 48 Hours of LifeJournal of Palliative Care, 1990